q.beyond AG

Original-Research: q.beyond AG (von NuWays AG): BUY

Original-Research: q.beyond AG - from NuWays AG

31.07.2024 / 09:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

Classification of NuWays AG to q.beyond AG

Company Name:q.beyond AG
ISIN:DE0005137004
 
Reason for the research:Update
Recommendation:BUY
from:31.07.2024
Target price:EUR 1.10
Last rating change:
Analyst:Philipp Sennewald

Q2 set to confirm strong first quarter improvements

Topic: q.beyond will report Q2/H1 figures on August 12th . We expect a slight sequential improvement  compared to the already strong first quarter.

Q2 sales are seen to increase 2.1% yoy to € 47.4m, which should again be driven by the Managed Service segment (eNuW: € 33.2m). On the other hand, we expect sales from the Consulting segment to slightly decline qoq to € 14.1m (eNuW), due to the continuous reduction in low-margin project sales. As we expect a slightly lower utilization in Q2 on the other hand, we hence expect the gross margin to remain stable at 8.5%. Mind you, that management is targeting to significantly increase the Consulting margin in the mid-term, driven by an increased utilization as well as a higher near- and off-shoring ratio (target: 20%, eNuW: 13% at H1 ’24). As the Managed Service margin should also remain stable, we expect the company to report a gross profit of € 8.3m for Q2, implying a 17.6% margin.

On this basis, Q2 EBITDA looks set to come in at € 2.1m (Q1: € 2.0m), implying a 4.3% margin as well as a 98% yoy improvement. Besides the already increased near- and off-shoring ratio, the strong yoy improvements should have been driven by continued implementation of the One q.beyond strategy allowing for cost reductions in sales & marketing as well as G&A.

With this, management should confirm the FY guidance of €  192-198m in sales (eNuW: €  194m), €  8-10m EBITDA (eNuW: € 9.7m) and a positive FCF (eNuW: € 6.0m). While our EBITDA forecast might look ambitious at first glance after H1 (eNuW: € 4.1m EBITDA), it should be justified by ongoing efficiency gains throughout the second half of the year.

Overall, the release is seen to fully support the company’s transformation according to its Strategy 2025, where management is targeting an EBITDA margin of 7-8% (eNuW: 7.1%) as well as a sustainable positive net income.

Valuation continues to look undemanding, as shares are trading at only 7.1x EV/EBITDA '24e (4.1x '25e). Hence, the stock remains a BUY with an unchanged PT of € 1.10 based on DCF.

You can download the research here: http://www.more-ir.de/d/30329.pdf
For additional information visit our website: www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

1957547  31.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1957547&application_name=news&site_id=ariva

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.